Related Experiment Video
Updated: Jan 20, 2026

Isolation of Human Umbilical Vein Endothelial Cells HUVEC
Published on: April 28, 2007
CTRP3 Protects against High Glucose-Induced Cell Injury in Human Umbilical Vein Endothelial Cells
Fang Wang1, Linlin Zhao1, Yingguang Shan2
1Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
C1q/tumor necrosis factor-related protein 3 (CTRP3) protects against high glucose-induced endothelial dysfunction by reducing inflammation and cell death. This protection is mediated through the AKT-mTOR signaling pathway, suggesting CTRP3 as a potential therapeutic agent.
Area of Science:
- Endocrinology
- Molecular Biology
- Cardiovascular Research
Background:
- Inflammation is a key factor in diabetes-related endothelial dysfunction.
- C1q/tumor necrosis factor-related protein 3 (CTRP3) has shown cardioprotective effects by reducing inflammation.
- The specific role of CTRP3 in high glucose-induced endothelial dysfunction requires further investigation.
Purpose of the Study:
- To evaluate the impact of CTRP3 on high glucose-induced inflammation and apoptosis in human umbilical vein endothelial cells (HUVECs).
- To elucidate the underlying molecular mechanisms, particularly the involvement of the AKT-mTOR signaling pathway.
Main Methods:
- HUVECs were pretreated with recombinant CTRP3 and then exposed to normal or high glucose conditions.
- Cell apoptosis, inflammatory factor production, and protein phosphorylation (AKT/mTOR) were assessed.
- The effects of AKT inhibition and endogenous CTRP3 knockdown were also examined.
Main Results:
- High glucose exposure reduced CTRP3 expression in HUVECs.
- Recombinant CTRP3 treatment attenuated high glucose-induced inflammation and apoptosis.
- CTRP3 enhanced AKT/mTOR phosphorylation, and this effect was blocked by AKT inhibition.
- Knockdown of CTRP3 exacerbated high glucose-induced inflammation and reduced cell viability.
Conclusions:
- CTRP3 treatment mitigates high glucose-induced endothelial inflammation and apoptosis via the AKT-mTOR signaling pathway.
- CTRP3 demonstrates potential as a therapeutic agent for preventing diabetes-related endothelial dysfunction.
Aims:
Inflammation was closely associated with diabetes-related endothelial dysfunction. C1q/tumor necrosis factor-related protein 3 (CTRP3) is a member of the CTRP family and can provide cardioprotection in many cardiovascular diseases via suppressing the production of inflammatory factors. However, the role of CTRP3 in high glucose- (HG-) related endothelial dysfunction remains unclear. This study evaluates the effects of CTRP3 on HG-induced cell inflammation and apoptosis.
Materials And Methods:
To prevent high glucose-induced cell injury, human umbilical vein endothelial cells (HUVECs) were pretreated with recombinant CTRP3 for 1 hour followed by normal glucose (5.5 mmol/l) or high glucose (33 mmol/l) treatment. After that, cell apoptosis and inflammatory factors were determined.
Results:
Our results demonstrated that CTRP3 mRNA and protein expression were significantly decreased after HG exposure in HUVECs. Recombinant human CTRP3 inhibited HG-induced accumulation of inflammatory factors and cell loss in HUVECs. CTRP3 treatment also increased the phosphorylation levels of protein kinase B (AKT/PKB) and the mammalian target of rapamycin (mTOR) in HUVECs. CTRP3 lost its inhibitory effects on HG-induced cell inflammation and apoptosis after AKT inhibition. Knockdown of endogenous CTRP3 in HUVECs resulted in increased inflammation and decreased cell viability in vitro.
Conclusions:
Taken together, these findings indicated that CTRP3 treatment blocked the accumulation of inflammatory factors and cell loss in HUVECs after HG exposure through the activation of AKT-mTOR signaling pathway. Thus, CTRP3 may be a potential therapeutic drug for the prevention of diabetes-related endothelial dysfunction.
More Related Videos
06:34New Application of an Atmospheric Pressure Plasma Jet as a Neuro-protective Agent Against Glucose Deprivation-induced Injury of SH-SY5Y Cells
Published on: October 9, 2017
10:25High-resolution Time-lapse Imaging and Automated Analysis of Microtubule Dynamics in Living Human Umbilical Vein Endothelial Cells
Published on: August 13, 2016
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Veins
Structure of Veins:
The structure of veins is specifically designed to assist in the low-pressure transportation of...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...